CÔNG TY CỔ PHẦN DƯỢC PHẨM MEDBOLIDE

VODOCAT REPORT AT THE DEPARTMENT OF CARDIOLOGY – CHO RAY HOSPITAL December 23, 2025

On December 23, 2025, Medbolide Pharmaceutical JSC attended the weekly scientific and technical seminar of the Department of Cardiology at Cho Ray Hospital. The seminar was attended by more than 50 cardiologists and was chaired by the Department Head, Associate Professor, Dr.Hoàng Văn Sỹ.

At the seminar, Dr. Đặng Quang Toàn presented and clarified the superior benefits of Torsemide compared to Furosemide based on scientific evidence from clinical studies. Torsemide is a loop diuretic with a superior mechanism of action compared to older diuretics, such as Furosemide, effectively reducing edema in patients with heart failure, kidney failure, and cirrhosis. Torsemide improves cardiac function and reduces the risk of death from heart failure.

The presentation drew significant interest and positive feedback from the doctors regarding the VODOCAT 5 product, which contains 5 mg of the active ingredient torsemide.

At the conclusion of the session, the company expressed its gratitude and hope to continue partnering with the hospital in providing effective solutions to enhance the quality of patient care. Medbolide Pharma JSC is proud to be a trusted partner of Cho Ray Hospital in supplying high-quality, effective medical products that contribute to the healthcare of the community.

Readers comments